ReviewJAC-antimicrobial resistance2025
Bacterial and fungal pathogens causing neonatal sepsis and associated antimicrobial resistance in South African neonatal units-a systematic review.
Review in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pathogens causing neonatal sepsis have developed resistance to antimicrobial treatment, resulting in the convergence of two public health issues; neonatal mortality and antimicrobial resistance. There are a few published studies presenting data from South Africa regarding neonatal sepsis pathogen and resistance profiles. Methods: We conducted a systematic review of bacterial and fungal neonatal sepsis pathogens and antimicrobial resistance profiles from 2005 to 2022. Results: Nine studies were included from 1235 screened. Most studies were from two provinces in South Africa and were conducted at academic hospitals. A single study included data collected nationally. Significant heterogeneity was noted, precluding the value of conducting a formal meta-analysis. There was significant variability in prevalence of pathogens, dependent on whether studies included coagulase negative Conclusion: The prevalence of pathogens causing neonatal sepsis in South Africa are consistent with those on the WHO list of priority bacterial and fungal pathogens. A high percentage resistance to WHO first and second line treatment is noted and emphasizes the importance of country specific surveillance for neonatal sepsis.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.